| Product Code: ETC6649910 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Angioedema Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Angioedema Market - Industry Life Cycle |
3.4 Canada Angioedema Market - Porter's Five Forces |
3.5 Canada Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Canada Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.7 Canada Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Canada Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 Canada Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Canada Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Canada Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of angioedema in Canada |
4.2.2 Growing awareness and diagnosis rates of angioedema |
4.2.3 Advancements in treatment options for angioedema |
4.3 Market Restraints |
4.3.1 High cost of treatment for angioedema |
4.3.2 Limited access to specialized healthcare services for angioedema patients |
5 Canada Angioedema Market Trends |
6 Canada Angioedema Market, By Types |
6.1 Canada Angioedema Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Angioedema Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Canada Angioedema Market Revenues & Volume, By Solid Dosage Form, 2021- 2031F |
6.1.4 Canada Angioedema Market Revenues & Volume, By Liquid Dosage Form, 2021- 2031F |
6.2 Canada Angioedema Market, By Route Of Administration |
6.2.1 Overview and Analysis |
6.2.2 Canada Angioedema Market Revenues & Volume, By Parenteral Route, 2021- 2031F |
6.2.3 Canada Angioedema Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 Canada Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 Canada Angioedema Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3 Canada Angioedema Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Canada Angioedema Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.3.3 Canada Angioedema Market Revenues & Volume, By Idiopathic Angioedema, 2021- 2031F |
6.3.4 Canada Angioedema Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.3.5 Canada Angioedema Market Revenues & Volume, By Drug-Induced Angioedema, 2021- 2031F |
6.3.6 Canada Angioedema Market Revenues & Volume, By Hereditary Angioedema, 2021- 2031F |
6.4 Canada Angioedema Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 Canada Angioedema Market Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021- 2031F |
6.4.3 Canada Angioedema Market Revenues & Volume, By Antihistamine, 2021- 2031F |
6.4.4 Canada Angioedema Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.5 Canada Angioedema Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.4.6 Canada Angioedema Market Revenues & Volume, By Adrenaline Injection, 2021- 2031F |
6.4.7 Canada Angioedema Market Revenues & Volume, By Hereditary Angioedema Drug Class, 2021- 2031F |
6.4.8 Canada Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.4.9 Canada Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.5 Canada Angioedema Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Canada Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 Canada Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 Canada Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 Canada Angioedema Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 Canada Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Canada Angioedema Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.6.4 Canada Angioedema Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Canada Angioedema Market Import-Export Trade Statistics |
7.1 Canada Angioedema Market Export to Major Countries |
7.2 Canada Angioedema Market Imports from Major Countries |
8 Canada Angioedema Market Key Performance Indicators |
8.1 Number of new diagnosed cases of angioedema annually |
8.2 Adoption rate of novel treatment options for angioedema |
8.3 Patient satisfaction with access to angioedema treatment and care |
9 Canada Angioedema Market - Opportunity Assessment |
9.1 Canada Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Canada Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.3 Canada Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Canada Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 Canada Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 Canada Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Canada Angioedema Market - Competitive Landscape |
10.1 Canada Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Canada Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here